SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-001746
Filing Date
2014-01-06
Accepted
2014-01-06 16:01:20
Documents
1
Period of Report
2014-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10738
  Complete submission text file 0001209191-14-001746.txt   12212
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address
Sumeray Mark (Reporting) CIK: 0001527134 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 14509782